WASHINGTON, D.C.—The molecular imaging power of PET/CT is invaluable in noninvasively monitoring Crohn’s disease—a chronic inflammatory disease of the gastrointestinal tract that mainly affects young people, according to a study released by Belgian scientists at the 54th Annual Meeting of SNM, the world’s largest society for molecular imaging and nuclear medicine professionals.
